Congresses

Marie Curie Lectures

’16: S. Barrington (UK)

PET/CT in Malignant Lymphoma    |   Watch Session


’15: S. Fanti (Italy)

Prostate Cancer    |   Watch Session


’14: M.J. Schlumberger (France)

Treatment of Differentiated Thyroid Cancer – State of the Art and New Developments    |   Watch Session


’13: J.J. Bax (The Netherlands)

Imaging of Coronary Artery Disease: Stenosis versus Perfusion


’12: V. Grégoire (Belgium)

Molecular Imaging Based Radiotherapy for Head and Neck Cancer


’11: A. J. McEwan (Canada)

The Future of Molecular Imaging in Enhancing Cancer Care


’10: I. Modlin (USA)

From Polonium to Lutetium: The Neuroendocrine Legacy of Curie


’09: V. Fuster (USA)

Diagnosing early atherothrombotic disease in the XXI century


’08: H. Maecke (Switzerland)

Therapeutic Radiopharmaceuticals


’07: I. Carrio (Spain)

Nuclear Medicine Research in old and new Europe


’06: R. Dierckx (The Netherlands)

Ta panta rei


’05: J. Knuuti (Finland)

Imaging of oxidative Metabolism: Insight into Cardiac Performance


’04: M. Schwaiger (Germany)

Prospects of PET and PET/CT in Cardiology


’03: E.P. Krenning (The Netherlands)

Radiolabelled peptides in oncology: present status and future directions.


’02: A. Cuocolo (Italy)

The Role of Nuclear Medicine in Clinical Decision making in Cardiology.


’01: P. Lind (Austria)

Treatment with radiopharmaceuticals: benign diseases


’00: P. Bourguet (France)

IRT: palliative or curative?


’99: G. Paganelli (Italy)

Sentinel node biopsy in breast cancer: from pilot study to randomized trial


’98: R.L. Wahl (Germany)

New therapies in Nuclear Medicine


’97: J.L. Moretti (France)

Updated applications and new trends in cerebral perfusion tracers

Back to top